tMN 2023

In 2022, NAnA was awarded a grant from the European Joint Programme on Rare Diseases for a project on rare diseases that proposed the organization of a networking event among experts in the field of oncohematology entitled “Highlights in therapy-related myeloid neoplasms.”


NAnA ETS is participating as a Patient Advocacy Organization (PAO) in the following European project funded by the Joint European Program on Rare Diseases: “Interaction between innate error of immunity and blood diseases: what immune defects underlie common hematological diseases.”

EP PerMed – JTC 2024 submitted

Characterization of Metabolic Deregulation for a New AML Risk Assessment and Personalized Therapeutic Targeting